Mumbai: Cadila Healthcare, the Zydus Cadilla Group flagship, has emerged as the frontrunner to acquire the generic sterile injectables business of Ahmedabad-headquartered Claris Lifesciences Ltd (CLL) trumping several domestic and global peers who ... India Brand Equity Foundation, 2 months ago
Cadila Healthcare eyes Claris arm for Rs 3,400 crore - Economic Times, 2 months ago
A move by Takeda Pharmaceutical to consolidate its Vaccine Business Unit into hubs should allow sharper focus on a complex set of vaccine programs covering norovirus, dengue and seasonal influenza in an increasingly competitive global horse race. ...Fierce CRO, 1 month ago
on your WebpageAdd Widget >Get your members hooked!